Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer dormancy

Cell stiffness regulates immune evasion during metastatic dormancy

Dormant metastases can lead to tumor relapse after many years by successfully escaping immune surveillance. A new study identifies an atypical epithelial-to-mesenchymal transition state that presents low stiffness mediated by actin depolymerization, which prevents immune cell-mediated killing of dormant metastatic lung adenocarcinoma.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: An atypical round and soft EMT state is crucial for survival and immune evasion of lung adenocarcinoma dormant metastatic cells.

References

  1. Massagué, J. & Obenauf, A. C. Nature 29, 298–306 (2016).

    Article  Google Scholar 

  2. Nieto, M. A., Huang, R. Y.-J., Jackson, R. A. & Thiery, J. P. Cell 166, 21–45 (2016).

    Article  CAS  PubMed  Google Scholar 

  3. Yang, J. et al. Nat. Rev. Mol. Cell Biol. 21, 341–352 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Puisieux, A., Brabletz, T. & Caramel, J. Nat. Cell Biol. 16, 488–494 (2014).

    Article  CAS  PubMed  Google Scholar 

  5. Pastushenko, I. et al. Nature 556, 463–468 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. Pastushenko, I. & Blanpain, C. Trends Cell Biol. 29, 212–226 (2019).

    Article  CAS  PubMed  Google Scholar 

  7. Pérez González, A., Bévant, K. & Blanpain, C. Nat. Cancer 4, 1063–1082 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Gerstberger, S., Jiang, Q. & Ganesh, K. Cell 186, 1564–1579 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Risson, E., Nobre, A. R., Maguer-Satta, V. & Aguirre-Ghiso, J. A. Nat. Cancer 1, 672–680 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wang, Z. et al. Nat. Cancer https://doi.org/10.1038/s43018-025-01094-y (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Massagué, J. & Sheppard, D. Cell 186, 4007–4037 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Goddard, E. T., Bozic, I., Riddell, S. R. & Ghajar, C. M. Nat. Cell Biol. 20, 1240–1249 (2018).

    Article  CAS  PubMed  Google Scholar 

  13. Basu, R. et al. Cell 165, 100–110 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Malladi, S. et al. Cell 165, 45–60 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hu, J. et al. Nature 616, 806–813 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

A.P.G. is supported by the ITN network EVOMET (955951). C.B. is supported by the WEL Research Institute, FNRS, TELEVIE, Fondation Contre le Cancer, the ULB Foundation, FNRS–FWO EOS (40007513) and European Research Council advanced grant TTTS (AdvGrant 885093).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cédric Blanpain.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pérez González, A., Blanpain, C. Cell stiffness regulates immune evasion during metastatic dormancy. Nat Cancer (2026). https://doi.org/10.1038/s43018-025-01096-w

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s43018-025-01096-w

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer